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Introduction 
West Nile Virus (WNV) belongs to the 
family Flaviviridae1-4 and is related to 
Japanese encephalitis.4,5 The virus usually is 
spread via the Culex mosquito with humans 
being an incidental reservoir.4,6 It is a febrile 
illness, which is accompanied by “flu-like” 
or nonspecific symptoms.  Most commonly, 
people present with myalgias, arthralgias, 
fever, and lymphadenopathy. More severely, 
it can present with, but not limited to nuchal 
rigidity, altered mental status, and per-
sonality changes.1,3,4   
WNV was identified first in 1937 in 
Uganda and since has been identified in 
parts of the Middle East and Asia.1,2,4  In the 
1950s, it was seen in Egypt and Israel, and 
moved West, causing a major outbreak of 
encephalitis in Romania in the 1990s.3,4  It 
also has been seen in other parts of Europe 
and Asia including, but not limited to, 
France, Italy, and India.4  Before 1999, only 
four arboviruses had been endemic in the 
United States: St. Louis encephalitis, eastern 
equine encephalitis, western equine enceph-
alitis, and La Crosse encephalitis.2 WNV 
first was identified in the US during an 
outbreak in New York in 1999.2,7,8 It 
initially was identified in Kansas in 2002.9 
A case of proven West Nile encephalitis 
is reported to illustrate the presentation of 
the viral encephalitis and to remind 
clinicians to keep it on their differential 
diagnosis. 
 
 
 
Case Report 
A 30-year-old Caucasian male known to 
have a history of seasonal allergy and well-
controlled asthma was transferred to the 
hospital from an outlying facility because of 
increased confusion and agitation. One week 
prior to presentation, the patient complained 
of nonspecific myalgias that were attributed 
to recent strenuous outdoor activity or 
possibly the onset of a flu-like illness.   
These symptoms were followed by a 
rash on his neck that was attributed to sun 
exposure and skin irritation. Over the next 
four days, the rash spread from the neck to 
include his back and arms.  A week later, he 
reported a fever of 102o Fahrenheit, along 
with recurrent nausea and vomiting, new 
onset of lethargy, and generalized weakness. 
He was taken to the local emergency room 
for further evaluation and hospitalized.  Due 
to increased agitation, the patient was 
transferred to our tertiary facility.  
During transport, the patient was 
agitated and required sedation. He was 
obtunded and intubated to protect his 
airway.  Supportive care was administered. 
On physical examination, the patient was 
afebrile. He was responsive to pain although 
intubated and sedated.  He did not exemplify 
nuchal rigidity.  Both Kernig and Brudzinski 
signs were absent. He underwent a lumbar 
puncture and was started on doxycycline to 
cover for suspected tick-borne illness due to 
his history of outdoor hobbies and febrile 
illness with rash.  
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Analysis of cerebrospinal fluid (CSF) 
showed pleocytosis with 585/mm3 leuko-
cytes of which 65% were lymphocytes and 
29% were neutrophils. CSF glucose was 
within normal range at 54 mg/dl, but protein 
was elevated at 119 mg/dl, with serum 
glucose of 88 mg/dL and serum protein of 
7.3 g/dL. Polymerase chain reaction (PCR) 
for Herpes Simplex Virus (HSV) and entero-
viruses were negative. Human Immunode-
ficiency Virus (HIV) serology was negative. 
Computed tomography (CT) without 
contrast and magnetic resonance imaging 
(MRI) with and without contrast showed 
normal anatomy.  Immunoglobulin G (IgG) 
and immunoglobulin M (IgM) on the 
cerebrospinal fluid for West Nile virus were 
positive at a 1:2 dilution. Serum IgG and 
IgM for West Nile were positive at greater 
than 1:320 dilutions. The diagnosis of West 
Nile encephalitis was confirmed. 
An infectious disease specialist was 
consulted. Doxycycline was discontinued 
and supportive care was recommended.  The 
patient was extubated, but continued to be 
agitated and confused. The patient’s 
agitation completely resolved prior to 
discharge, and he began to recall details of 
his illness prior to hospitalization. Although 
his confusion resolved, he had some 
difficulty recalling short term memory 
items. With the help of physical and 
occupational therapy, the patient began to 
regain strength. He was dismissed home 
with outpatient physical therapy to assist 
him with residual weakness. 
 
Discussion 
This case of WNV infection was 
transmitted more than likely via a mosquito, 
as human to human transmission is very 
rare, and the patient had no history of recent 
blood transfusion.10 Since 2003, the 
incidence of WNV has decreased. In the US, 
386 cases of neuro-invasive WNV were 
reported, spanning from May through 
October 2009.11 From 2006-2008, the 
median number of confirmed cases of neuro-
invasive WNV in Kansas was five per 
year.10 In each of 2009 and 2010, there were 
three neuro-invasive cases in Kansas.12   
Most individuals who encounter WNV 
present with flu-like symptoms and usually 
have unsuspected, hence unreported, cases.  
Less than 1% of reported cases will have 
neurological manifestations of the virus,4 
such as acute flaccid paralysis, headache, 
dyskinesias, confusion, agitation, or obtund-
ation.4,13-16 Risk factors for more severe 
presentation of WNV include having 
comorbidities (i.e., diabetes mellitus or 
hypertension), prolonged steroid use, age 50 
years or older, and immunocompromise.13,15  
Initially presenting with severe illness does 
not correlate with poor prognosis.14 The 
diagnosis of WNV can be made with clinical 
suspicion and detection of IgM to the virus 
on CSF, serum, or tissue.13,15,16  The criteria 
to make the diagnosis of WN encephalitis 
are outlined in Table 1. 
Differentiating WN encephalitis from 
WN meningitis can be challenging.  
Diagnostic criteria for both include fever, 
leukocytosis, and pleocytosis on CSF.14   
However, with WN meningitis, the patient 
may exhibit nuchal rigidity, phonophobia, 
photophobia, and/or Kernig or Brudzinski 
sign. In addition, imaging may show 
findings consistent with acute meningeal 
inflammation, however, findings on imaging 
are not necessary to make the diagnosis.   
In contrast with WN encephalitis, the 
patient may not show meningeal signs.  The 
patient may show confusion, agitation, 
obtundation, irritability or, personality 
changes.14 Imaging of WN encephalitis may 
show acute inflammation without involving 
the meninges, suggesting a meningo-
encephalitis. CT of the head rarely exhibits 
clinical findings, whereas an MRI may show 
enhancement of the periventricular area or 
the leptomeninges.15,16 
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Table 1.  The criteria to make the diagnosis of WN encephalitis.13 
Febrile illness with neurological manifestations (headache, aseptic meningitis, myelitis) 
plus at least one of the following: 
1. Isolation of WNV from tissue, blood, CSF, or other body fluids. 
2. Demonstration of WN viral antigen or genomic sequence in tissue, blood, CSF, or other 
body fluids. 
3. Demonstration of WN IgM antibody in acute CSF sampling using MAC-ELISA. 
4. Demonstration of 4-fold change in PRNT antibody titer to WNV in paired, appropriately 
timed acute and convalescent serum samples. 
5. Demonstration of WNV-specific IgM (by MAC-ELISA) and IgG (by ELISA or HI 
antibody titer, confirmed by PRNT) in a single serum sample. 
 
CSF analysis in WN encephalitis may 
show pleocytosis with a predominance of 
lymphocytes that rarely exceeds 100 
cells/microliter. Protein may be elevated and 
glucose usually is within normal range.16 
Our patient's CSF analysis showed a 
lymphocyte predominant pleocytosis, but 
the cell count was greater than 100 
cells/microliter.  Protein was elevated and 
glucose was normal. 
Unlike other encephalitic viruses, WN 
encephalitis patients usually have a good 
prognosis and do not manifest long-term 
side effects, though it may take time to 
recover with rehabilitation.4,14 The treatment 
of WN encephalitis usually is supportive 
care. Ribavirin has been used, but did not 
show any clinical significant benefit.4,13 
Interferon alpha-2b has shown some 
promise in animal models, particularly when 
combined with ribavirin. In regard to human 
treatment, further research is warranted. 17 
 
Conclusions 
In conclusion, during the warmer months 
of the year, WNV should be included in the 
differential diagnoses when a patient 
presents with flu-like symptoms, especially 
in those with neurological changes. Our 
patient presented with nonspecific flu-like 
symptoms followed by generalized weak-
ness and increased agitation.  In light of the 
patient’s neurological manifestations and 
other reported cases of WNV within the 
patient’s state of residence, suspicion of 
WNV was high. WN IgM was isolated in 
the CSF as well as in the serum.  The patient 
continued to improve and required only 
outpatient physical therapy on dismissal. 
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